The Clinical Evaluation of Two Daily Disposable Contact Lenses
NCT ID: NCT00762996
Last Updated: 2018-06-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2007-08-31
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Comparison of Two Daily Disposable Contact Lenses.
NCT00775021
Evaluation of Etafilcon A Daily Disposable Lenses
NCT02061592
Clinical Evaluation of Two Daily Disposable Contact Lenses
NCT01163760
A Comparison of Two Daily Disposable Contact Lenses
NCT00600080
Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear
NCT01669629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
etafilcon A/etafilcon A
Period 1: etafilcon A, Period 2: etafilcon A
etafilcon A
contact lens
etafilcon A/omafilcon A
Period 1: etafilcon A, Period 2: omafilcon A
etafilcon A
contact lens
omafilcon A
contact lens
omafilcon A/etafilcon A
Period 1: omafilcon A, Period 2: etafilcon A
etafilcon A
contact lens
omafilcon A
contact lens
omafilcon A/omafilcon A
Period 1: omafilcon A, Period 2: omafilcon A
omafilcon A
contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
etafilcon A
contact lens
omafilcon A
contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
* They are willing and able to follow the protocol.
* They would be expected to attain at least 6.9 (20/30) in each eye with the study lenses.
* They are able to wear contact lenses which have a back vertex power of -1.00 to -6.00DS.
* They have a maximum of 1.00D of refractive astigmatism (i.e. \< 1.00 DC).
* They have worn soft contact lenses within six months of starting the study.
Exclusion Criteria
* They have a systemic disorder which would normally contra-indicate contact lens wear.
* They are using any topical medication such as eye drops or ointment.
* They are aphakic.
* They have had corneal refractive surgery.
* They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
* They are pregnant or lactating.
* They have grade 2 or greater of any of the following ocular surface signs: corneal edema, corneal vascularization, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
* They have any infectious disease (e.g., hepatitis) or any immunosuppressive disease (e.g., HIV).
* They have diabetes.
* They are currently taking part in any other clinical study or research.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eurolens Research
INDUSTRY
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eurolens Research
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-0707
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.